Retractable Technologies, Inc. (NYSEMKT:RVP) to Release Earnings on Monday
Retractable Technologies (NYSEMKT:RVP) last posted its earnings results on Monday, May 15th. The company reported ($0.04) earnings per share for the quarter. The business had revenue of $6.92 million for the quarter. Retractable Technologies had a negative return on equity of 19.77% and a negative net margin of 17.19%.
Retractable Technologies, Inc. (NYSEMKT:RVP) traded down 2.31% during midday trading on Friday, reaching $1.27. The company had a trading volume of 66,732 shares. The firm’s market capitalization is $40.22 million. Retractable Technologies, Inc. has a 12 month low of $0.88 and a 12 month high of $2.79. The firm’s 50-day moving average price is $1.25 and its 200 day moving average price is $1.11.
ILLEGAL ACTIVITY WARNING: “Retractable Technologies, Inc. (NYSEMKT:RVP) to Release Earnings on Monday” was first published by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/retractable-technologies-inc-nysemktrvp-to-release-earnings-on-monday/1475892.html.
About Retractable Technologies
Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.
Receive News & Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.